Hirofumi Suzuki has a PhD in pharmaceutical sciences from Okayama University and MBA from NUCB. He has been Senior Regulatory CMC Adviser since February 01, 2019 of Bayer Yakuhin Ltd. Japan. He served as Head of CMC of Bayer Yakuhin from 2007 until 2019. In this position he managed Regulatory activities, Pharmaceutical Development, Investigation...
Roles at ISPE